Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Conditions:   Esophageal Neoplasms;   Esophageal Diseases;   Gastrointestinal Diseases;   Gastrointestinal Neoplasms
Interventions:   Drug: Radiation;   Drug: SHR-1210
Sponsors:   Hangzhou Cancer Hospital;   Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified June 2017

http://ift.tt/2tnGLU3